Oracle may be closing in on $30B purchase of EMR giant Cerner

Oracle, one of the largest software companies in the world, is closing in on the purchase of Cerner for an estimated $30 billion, the Wall Street Journal reported Thursday.

People familiar with the matter said negotiations could be finalized soon and would be considered the largest ever for Oracle. The move would push the software giant further into the cloud and healthcare spaces as it seeks to compete with the likes of Amazon and Microsoft.

Kansas City, Missouri-based Cerner currently has a market cap of about $23 billion and recently hired former Geisinger CEO and Google Health leader David Feinberg as its chief executive officer.

Oracle, meanwhile, boasts a value of more than $280 billion, making it the second-biggest software venture in the world by revenue and market capitalization.

A deal for Cerner would surpass Oracle’s largest transaction to date, approximately $10 billion it paid to buy enterprise-software firm PeopleSoft in 2005. It also acquired NetSuite, a cloud provider, for $9 billion in 2016.

Read the full story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.